ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut

investorplace2021-06-18

23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday. Here’s everything investorsneed to know about the company and it going public. ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

Shuanggyang
2021-06-21
Shuanggyang
[财迷]
EricTan4527
2021-06-21
EricTan4527
Oh
Popcornn
2021-06-21
Popcornn
Wow
jolinisme
2021-06-21
jolinisme
Oh
WhinnyWinny
2021-06-20
WhinnyWinny
[Great]
Wongwonggg
2021-06-20
Wongwonggg
Good

发表看法

209

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1135760972?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-06-18 22:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1135760972","market":"us","top_or_hot":-1,"title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","media":"investorplace","content":"<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">网页链接</a>\n\n</div>\n","source":"lsy1606302653667","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ME","symbol_name":"23andMe, Inc.","start_time":0,"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","article_id":"1135760972","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","pubTimestamp":1624026807,"sourceInfo":{"source_id":"lsy1606302653667","name":"InvestorPlace"},"weMediaInfo":null,"summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","collect":0,"end_time":0,"defaultTopTitle":"investorplace.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"ME":"23andMe, Inc."},"translate_title":"《我的股票》:23andMe纳斯达克上市后投资者应了解的14件事","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ME":0.9},"content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":164433705,"gmtCreate":1624232732707,"gmtModify":1634009297298,"author":{"id":"3574887418287176","authorId":"3574887418287176","name":"Shuanggyang","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3574887418287176","idStr":"3574887418287176"},"htmlText":"[财迷]&nbsp;","listText":"[财迷]&nbsp;","text":"[财迷]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/164433705","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","pubTimestamp":1624026807,"share":"https://www.laohu8.com/m/news/1135760972?lang=&edition=full","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":164524408,"gmtCreate":1624231011004,"gmtModify":1631890388507,"author":{"id":"3586315254285458","authorId":"3586315254285458","name":"EricTan4527","avatar":"https://static.tigerbbs.com/d44236c4ebf7d2188154b3ab2c05456a","vip":1,"crmLevel":7,"crmLevelSwitch":0,"authorIdStr":"3586315254285458","idStr":"3586315254285458"},"htmlText":"Oh","listText":"Oh","text":"Oh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/164524408","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","pubTimestamp":1624026807,"share":"https://www.laohu8.com/m/news/1135760972?lang=&edition=full","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":164505132,"gmtCreate":1624226013326,"gmtModify":1634009411089,"author":{"id":"3574394359789498","authorId":"3574394359789498","name":"Popcornn","avatar":"https://static.tigerbbs.com/a9963e628c84bc7aa6308556a38d7360","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3574394359789498","idStr":"3574394359789498"},"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/164505132","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","pubTimestamp":1624026807,"share":"https://www.laohu8.com/m/news/1135760972?lang=&edition=full","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":164265532,"gmtCreate":1624209300626,"gmtModify":1634009451825,"author":{"id":"3574936536300157","authorId":"3574936536300157","name":"jolinisme","avatar":"https://static.tigerbbs.com/1091498047118bdffdd80375a3e55929","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3574936536300157","idStr":"3574936536300157"},"htmlText":"Oh","listText":"Oh","text":"Oh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/164265532","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","pubTimestamp":1624026807,"share":"https://www.laohu8.com/m/news/1135760972?lang=&edition=full","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":164640569,"gmtCreate":1624203396451,"gmtModify":1634009517405,"author":{"id":"3583917916714733","authorId":"3583917916714733","name":"WhinnyWinny","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3583917916714733","idStr":"3583917916714733"},"htmlText":"[Great]&nbsp;","listText":"[Great]&nbsp;","text":"[Great]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/164640569","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","pubTimestamp":1624026807,"share":"https://www.laohu8.com/m/news/1135760972?lang=&edition=full","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":164808406,"gmtCreate":1624187440905,"gmtModify":1634009672622,"author":{"id":"3586849282716963","authorId":"3586849282716963","name":"Wongwonggg","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3586849282716963","idStr":"3586849282716963"},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/164808406","repostId":1135760972,"repostType":4,"repost":{"id":"1135760972","pubTimestamp":1624026807,"share":"https://www.laohu8.com/m/news/1135760972?lang=&edition=full","pubTime":"2021-06-18 22:33","market":"us","language":"en","title":"ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1135760972","media":"investorplace","summary":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq","content":"<p><b>23andMe</b>(NASDAQ:<b><u>ME</u></b>) stock is on the move Friday after the company made its public debut on the&nbsp;<b>Nasdaq Exchange</b>&nbsp;yesterday.</p>\n<p>Here’s everything investorsneed to know about the company and it going public.</p>\n<ul>\n <li>To start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.</li>\n <li>Instead, the company combined with special purpose acquisition company (SPAC)<b>VG Acquisition</b>.</li>\n <li>That SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.</li>\n <li>The merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.</li>\n <li>23andMe is keeping its current leadership team, but with some minor changes.</li>\n <li>That includes two executives from VG Acquisition joining the company’s Board of Directors.</li>\n <li>23andMe is a consumer genetics and research company.</li>\n</ul>\n<ul>\n <li>It was founded in 2006 and is headquartered in Sunnyvale, Calif.</li>\n <li>The goal of the company is to better help its customers understand their own genetic information.</li>\n <li>Its work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).</li>\n <li>The company uses its research into the human genome to develop drugs to treat a variety of diseases.</li>\n <li>That includes oncology, respiratory, and cardiovascular diseases.</li>\n <li>Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands.</li>\n <li>That’s approaching its average daily trading volume of 1.2 million shares.</li>\n</ul>\n<p>ME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nME Stock: 14 Things for Investors to Know About 23andMe Following Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n...</p>\n\n<a href=\"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ME":"23andMe, Inc."},"source_url":"https://investorplace.com/2021/06/me-stock-14-things-for-investors-to-know-about-23andme-following-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135760972","content_text":"23andMe(NASDAQ:ME) stock is on the move Friday after the company made its public debut on the Nasdaq Exchange yesterday.\nHere’s everything investorsneed to know about the company and it going public.\n\nTo start off with, 23andMe didn’t use an initial public offering (IPO) for its debut.\nInstead, the company combined with special purpose acquisition company (SPAC)VG Acquisition.\nThat SPAC merger closed on Wednesday, which saw shares of ME stock start trading publically on Thursday.\nThe merger resulted in it raising $592 million in gross proceeds, which it plans to use in expanding its consumer health and therapeutics businesses.\n23andMe is keeping its current leadership team, but with some minor changes.\nThat includes two executives from VG Acquisition joining the company’s Board of Directors.\n23andMe is a consumer genetics and research company.\n\n\nIt was founded in 2006 and is headquartered in Sunnyvale, Calif.\nThe goal of the company is to better help its customers understand their own genetic information.\nIts work has also resulted in several authorizations for genetic health risk reports from the U.S. Food and Drug Administration (FDA).\nThe company uses its research into the human genome to develop drugs to treat a variety of diseases.\nThat includes oncology, respiratory, and cardiovascular diseases.\nTrading for ME stock is starting off heavy today with some 1.1 million shares trading hands.\nThat’s approaching its average daily trading volume of 1.2 million shares.\n\nME stock was down 3.8% in early trading on Friday after surging higher during trading on Thursday.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":209,"commentSize":82,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1135760972"}